Today, Bumrungrad International Hospital Declares it is MERS-Free All Employees under Observation Return Home

Food and Healthcare Press Releases Thursday July 2, 2015 15:03
Bangkok--2 Jul--Bumrungrad International Hospital

Bumrungrad International Hospital announced today that the Department of Disease Control, under the Ministry of Public Health, has allowed all employees under observation at the hospital to return home. Thus, on July 2, 2015, there are no suspected cases of MERS-CoV at Bumrungrad and the hospital is MERS-Free.

The announcement of the first confirmed case of MERS-CoV in Thailand was made on June 18, 2015. Bumrungrad International Hospital was the one to detect the suspected MERS-CoV case and carried out its strict protocols for isolating and preventing the spread of the disease to other staff or patients, and safely transferred the patient for further treatment at the Bamrasnaradura Infectious Diseases Institute under the jurisdiction of the Ministry of Public Health, as per MoPH directions.

Bumrungrad also reported that it will continue to uphold its strict safety measures for the safety of its patients, visitors, employees, and the community. Examples include the Thermo Scan machines that measure body temperature, a Special Screening Clinic, and the addition of Airborne Infection Isolation rooms to screen patients who are in the high-risk group while preventing contamination with other patients; stricter and more frequent disinfection of floors and public equipment; close collaboration with the Department of Disease Control under the Ministry of Public Health to increase measures for monitoring and preventing MERS-CoV; and the management team constantly monitors the situation and meets with experts to adjust plans for dealing with the situation as appropriate.

Bumrungrad's strict protocols that have been practiced continuously has enabled the hospital to handle the situation correctly and quickly, garnering praise from the Ministry of Public Health, the Department of Disease Control, and Department of Health Service Support, and experts from various institutions, including the World Health Organization (WHO) and many news agencies.

Bumrungrad assures you that with the hospital's standard protocols and increased safety measures, meeting and even surpassing the guidelines of the World Health Organization (WHO) and the Central for Disease Control and Prevention (CDC) of the United States, it is confident in its ability to handle situations similar to these now and in the future.


Latest Press Release

Novo Nordisk (Thailand) is hosting a press conference for the topic of Rethink Obesity.

Mr. John Dawber, Vice President and General Manager at Novo Nordisk (Thailand) is hosting a press conference for the topic of "Rethink Obesity". The event will be chaired by His Excellency Mr. Uffe Wolffhechel, Ambassador of Denmark to Thailand, and will...

Brain Health Supplements Market Expecting an Outstanding Growth Till 2025

The global brain health supplements market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.2% over the forecast period. Growing health concerns over depression, anxiety,...

Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT(TM), a volume reduction instrument optimized to remove manual sample volume reduction steps in cellular biology...

BREASTFEEDING CAMPAIGN SETS A NEW REGIONAL STANDARD FOR SUSTAINABLE COMMUNICATION

The "6 months mother's milk is all you need" campaign has been awarded South East Asia PR Campaign of the year and Cause related public awareness campaign of the Year by Campaign Asia at the PR awards in Hong Kong last month. Initiated by Save The...

Daewoong Pharmaceutical participated in the IMCAS Asia 2019 to introduce the excellence of NABOTA

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia July 5-7, 2019 to introduce the excellence of NABOTA(R) (Prabotulinumtoxin A). The 13th year...

Related Topics